Related Experiment Video

Updated: Sep 21, 2026

Assessing Murine Resistance Artery Function Using Pressure Myography
07:25

Assessing Murine Resistance Artery Function Using Pressure Myography

Published on: June 7, 2013

Target Organ Damage in Hypertension

Unini Odama1, George Bakris

  • 1Rush Hypertension Center, Department of Preventive Medicine, Rush Presbyterian St. Luke's Medical Center, Chicago, IL.

Journal of Clinical Hypertension (Greenwich, Conn.)
|June 21, 2001
PubMed

Insights

Achieving blood pressure goals is critical for managing hypertension and diabetes, reducing risks of kidney failure and cardiovascular events. Aggressive blood pressure lowering is essential for patients with target organ injury.

Area of Science:

  • Cardiology
  • Nephrology
  • Endocrinology

Background:

  • Hypertension and diabetes are leading causes of renal failure and cardiovascular death in Western countries.
  • A significant percentage of the population, especially those with diabetes, do not meet recommended blood pressure goals.
  • Low rates of achieving target blood pressure contribute to ongoing cardiovascular morbidity and rising dialysis rates.

Purpose of the Study:

  • To highlight the critical need for aggressive blood pressure management in patients with hypertension and diabetes.
  • To emphasize the link between target organ injury and increased cardiovascular and renal event rates.
  • To advocate for stricter blood pressure control to prevent cardiovascular and renal complications.

Main Methods:

  • Analysis of population data (NHANES III) to assess blood pressure goal achievement rates.
  • Review of clinical indicators of target organ injury (left ventricular hypertrophy, microalbuminuria).
  • Examination of the association between blood pressure control, target organ injury, and cardiovascular/renal outcomes.

Main Results:

  • Only 27.4% of individuals achieve goal blood pressure, with only 11% of diabetic patients meeting the <130/85 mm Hg target.
  • Target organ injury, including left ventricular hypertrophy and microalbuminuria, indicates prolonged pressure overload.
  • These injuries are associated with significantly higher rates of cardiovascular events and renal disease progression.

Conclusions:

  • Patients with hypertension and diabetes require aggressive blood pressure lowering to prevent cardiovascular and renal disease.
  • Early identification and management of target organ injury are crucial for improving patient outcomes.
  • Adherence to guidelines, such as those from JNC VI, is vital for reducing cardiovascular and renal morbidity and mortality.

More Related Videos

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension05:57

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension

Published on: May 17, 2024

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Antihypertensive Drugs: Action of &#946;1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...